2008 Clinical Practice Guidelines - Canadian Diabetes Association

2008 CLINICAL PRACTICE GUIDELINES
S158
Effect of intensive treatment of diabetes on the development
and progression of long-term complications in insulin-dependent
diabetes mellitus. N Engl J Med. 1993;329:977-986.
4. Diabetes Control and Complications Trial Research Group.
Effect of intensive diabetes treatment on the development and
progression of long-term complications in adolescents with
insulin-dependent diabetes mellitus: Diabetes Control and
Complications Trial. J Pediatr. 1994;125:177-188.
5. Ryan C, Gurtunca N, Becker D. Hypoglycemia: a complication
of diabetes therapy in children. Pediatr Clin North Am. 2005;52:
1705-1733.
6. Schoenle EJ, Schoenle D, Molinari L, et al. Impaired intellectual
development in children with Type I diabetes: association
with HbA(1c), age at diagnosis and sex. Diabetologia. 2002;45:
108-114.
7. Ferguson SC, Blane A,Wardlaw J, et al. Influence of an earlyonset
age of type 1 diabetes on cerebral structure and cognitive
function. Diabetes Care. 2005;28:1431-1437.
8. Strudwick SK, Carne C, Gardiner J, et al. Cognitive functioning
in children with early onset type 1 diabetes and severe
hypoglycemia. J Pediatr. 2005;147:680-685.
9. Phillip M, Battelino T, Rodriguez H, et al. Use of insulin pump
therapy in the pediatric age-group. Consensus statement from
the European Society for Paediatric Endocrinology, the
Lawson Wilkins Pediatric Endocrine Society, and the
International Society for Pediatric and Adolescent Diabetes,
endorsed by the American Diabetes Association and the
European Association for the Study of Diabetes. Diabetes Care.
2007;30:1653-1662.
10. Fox LA, Buckloh LM, Smith SD, et al. A randomized controlled
trial of insulin pump therapy in young children with
type 1 diabetes. Diabetes Care. 2005;28:1277-1281.
11. DiMeglio LA, Pottorff TM, Boyd SR, et al.A randomized, controlled
study of insulin pump therapy in diabetic preschoolers.
J Pediatr. 2004;145:380-384.
12. Wilson DM, Buckingham BA, Kunselman EL, et al. A twocenter
randomized controlled feasibility trial of insulin pump
therapy in young children with diabetes. Diabetes Care. 2005;
28:15-19.
13. Weintrob N, Benzaquen H, Galatzer A, et al. Comparison of
continuous subcutaneous insulin infusion and multiple daily
injection regimens in children with type 1 diabetes: a randomized
open crossover trial. Pediatrics. 2003;112:559-564.
14. Doyle EA, Weinzimer SA, Steffen AT, et al. A randomized,
prospective trial comparing the efficacy of continuous subcutaneous
insulin infusion with multiple daily injections using
insulin glargine. Diabetes Care. 2004;27:1554-1558.
15. Weinzimer SA, Sikes KA, Steffen AT, et al. Insulin pump treatment
of childhood type 1 diabetes. Pediatr Clin North Am. 2005;
52:1677-1688.
16. Alemzadeh R, Berhe T,Wyatt DT. Flexible insulin therapy with
glargine insulin improved glycemic control and reduced severe
hypoglycemia among preschool-aged children with type 1 diabetes
mellitus. Pediatrics. 2005;115:1320-1324.
17. Murphy NP, Keane SM, Ong KK, et al. Randomized cross-over
trial of insulin glargine plus lispro or NPH insulin plus regular
human insulin in adolescents with type 1 diabetes on intensive
insulin regimens. Diabetes Care. 2003;26:799-804.
18. Robertson KJ, Schoenle E, Gucev Z, et al. Insulin detemir
compared with NPH insulin in children and adolescents with
Type 1 diabetes. Diabet Med. 2007;24:27-34.
19. Nordly S, Mortensen HB, Andreasen AH, et al. Factors associated
with glycaemic outcome of childhood diabetes care in
Denmark. Diabet Med. 2005;22:1566-1573.
20. Diabetes Research in Children Network (DIRECNET) Study
Group.The accuracy of the CGMS in children with type 1 diabetes:
results of the diabetes research in children network
(DirecNet) accuracy study. Diabetes Technol Ther. 2003;5:781-
789.
21. Fiallo-Scharer R, Diabetes Research in Children Network
Study Group. Eight-point glucose testing versus the continuous
glucose monitoring system in evaluation of glycemic control
in type 1 diabetes. J Clin Endocrinol Metab. 2005;90:
3387-3391.
22. Tansey MJ, Beck RW, Buckingham BA, et al. Accuracy of the
modified Continuous Glucose Monitoring System (CGMS)
sensor in an outpatient setting: results from a Diabetes
Research in Children Network (DirecNet) Study. Diabetes
Technol Ther. 2005;7:109-114.
23. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control
in poorly controlled patients with type 1 diabetes using
real-time continuous glucose monitoring. Diabetes Care. 2006;
29:2730-2732.
24. Health Canada. Eating Well with Canada’s Food Guide. Ottawa,
ON: Health Canada, Health Products and Food Branch, Office
of Nutrition Policy and Promotion; 2007. Publication H39-
166/1990E.
25. Kaufman FR, Halvorson M, Carpenter S. Use of a plastic
insulin dosage guide to correct blood glucose levels out of the
target range and for carbohydrate counting in subjects with
type 1 diabetes. Diabetes Care. 1999;22:1252-1257.
26. Patton SR, Dolan LM, Powers SW. Dietary adherence and
associated glycemic control in families of young children with
type 1 diabetes. J Am Diet Assoc. 2007;107:46-52.
27. Hartley M, Thomsett MJ, Cotterill AM. Mini-dose glucagon
rescue for mild hypoglycaemia in children with type 1 diabetes:
the Brisbane experience. J Paediatr Child Health. 2006;
42:108-111.
28. Haymond MW, Schreiner B. Mini-dose glucagon rescue for
hypoglycemia in children with type 1 diabetes. Diabetes Care.
2001;24:643-645.
29. Northam EA, Todd S, Cameron FJ. Interventions to promote
optimal health outcomes in children with Type 1 diabetes—are
they effective? Diabet Med. 2006;23:113-121.
30. Wysocki T, Buckloh LM, Lochrie AS, et al. The psychologic
context of pediatric diabetes. Pediatr Clin North Am. 2005;
52:1755-1778.
31. Levy-Marchal C, Patterson CC, Green A. Geographic variation